Cargando…
An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatment
BACKGROUND: Novel theranostic options for high-risk non-muscle invasive bladder cancer are urgently needed. This requires a thorough evaluation of experimental approaches in animal models best possibly reflecting human disease before entering clinical studies. Although several bladder cancer xenogra...
Autores principales: | Huebner, Doreen, Rieger, Christiane, Bergmann, Ralf, Ullrich, Martin, Meister, Sebastian, Toma, Marieta, Wiedemuth, Ralf, Temme, Achim, Novotny, Vladimir, Wirth, Manfred P., Bachmann, Michael, Pietzsch, Jens, Fuessel, Susanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701455/ https://www.ncbi.nlm.nih.gov/pubmed/29169339 http://dx.doi.org/10.1186/s12885-017-3778-3 |
Ejemplares similares
-
Minimally Invasive Establishment of Murine Orthotopic Bladder Xenografts
por: Jäger, Wolfgang, et al.
Publicado: (2014) -
Dasatinib enhances tumor growth in gemcitabine-resistant orthotopic bladder cancer xenografts
por: Vallo, Stefan, et al.
Publicado: (2016) -
Enhanced Inhibition of Bladder Cancer Cell Growth by Simultaneous Knockdown of Antiapoptotic Bcl-xL and Survivin in Combination with Chemotherapy
por: Kunze, Doreen, et al.
Publicado: (2013) -
RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivo
por: Hendruschk, Sandy, et al.
Publicado: (2011) -
Overexpression of Receptor Tyrosine Kinase EphB4 Triggers Tumor Growth and Hypoxia in A375 Melanoma Xenografts: Insights from Multitracer Small Animal Imaging Experiments (‡)
por: Neuber, Christin, et al.
Publicado: (2018)